NEM vs TECH · P/E 14, rev $22.67B vs P/E 65, rev $1.22B
Newmont Goldcorp Corp (NEM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NEM revenue for 2025-12-31 was $22.67B. Net income was $7.08B. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NEM currently screens at market cap $112.81B and trailing P/E 13.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NEM and TECH stock pages for the full models.
Not investment advice.